18800559. COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK (Novartis AG)
COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK
Organization Name
Inventor(s)
Erich W. Baum of South Hamilton MA US
Thomas A. Dineen, Jr. of Somerville MA US
Jonathan Edward Hempel of Arlington MA US
Matthew James Hesse of Oakland CA US
Robert Koenig of Braintree MA US
Matthew James Lamarche of Reading MA US
Jay Francis Larrow of Wakefield MA US
Henrik Moebitz of Arlesheim CH
Rukundo Ntaganda of Weymouth MA US
Keith Bruce Pfister of San Ramon CA US
Martin Sendzik of Belmont MA US
Colin Keith Skepper of Alameda CA US
Joseph Wzorek, Jr. of Watertown MA US
Frédéric Zecri of Belmont MA US
COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK
This abstract first appeared for US patent application 18800559 titled 'COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK
Original Abstract Submitted
The invention relates to compounds which modulate the activity of ERK. The present invention also relates to processes for the preparation of said compounds, pharmaceutical compositions comprising said compounds, and use of said compounds in the treatment of conditions, diseases and disorders mediated by ERK.
- Novartis AG
- Erich W. Baum of South Hamilton MA US
- Thomas A. Dineen, Jr. of Somerville MA US
- Jonathan Edward Hempel of Arlington MA US
- Matthew James Hesse of Oakland CA US
- Robert Koenig of Braintree MA US
- Matthew James Lamarche of Reading MA US
- Jay Francis Larrow of Wakefield MA US
- Ruowei Mo of New Hope PA US
- Henrik Moebitz of Arlesheim CH
- Rukundo Ntaganda of Weymouth MA US
- Keith Bruce Pfister of San Ramon CA US
- Martin Sendzik of Belmont MA US
- Colin Keith Skepper of Alameda CA US
- Joseph Wzorek, Jr. of Watertown MA US
- Frédéric Zecri of Belmont MA US
- C07D471/04
- A61K31/454
- A61K31/4545
- A61P35/00
- C07D401/06
- C07D405/14
- C07D491/052
- CPC C07D471/04
(Ad) Transform your business with AI in minutes, not months
Trusted by 1,000+ companies worldwide
